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Abstract
Objective—To test how genomic loci identified in genome-wide association studies influence
the development of obesity.
Design—A 38-year prospective longitudinal study of a representative birth cohort.
Setting—The Dunedin Multidisciplinary Health and Development Study, Dunedin, New
Zealand.
Participants—One thousand thirty-seven male and female study members.
Main Exposures—We assessed genetic risk with a multilocus genetic risk score. The genetic
risk score was composed of single-nucleotide polymorphisms identified in genome-wide
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association studies of obesity-related phenotypes. We assessed family history from parent body
mass index data collected when study members were 11 years of age.
Main Outcome Measures—Body mass index growth curves, developmental phenotypes of
obesity, and adult obesity outcomes were defined from anthropometric assessments at birth and at
12 subsequent in-person interviews through 38 years of age.
Results—Individuals with higher genetic risk scores were more likely to be chronically obese in
adulthood. Genetic risk first manifested as rapid growth during early childhood. Genetic risk was
unrelated to birth weight. After birth, children at higher genetic risk gained weight more rapidly
and reached adiposity rebound earlier and at a higher body mass index. In turn, these
developmental phenotypes predicted adult obesity, mediating about half the genetic effect on adult
obesity risk. Genetic associations with growth and obesity risk were independent of family history,
indicating that the genetic risk score could provide novel information to clinicians.
Conclusions—Genetic variation linked with obesity risk operates, in part, through accelerating
growth in the early childhood years after birth. Etiological research and prevention strategies
should target early childhood to address the obesity epidemic.
Obesity is known to be heritable, and genome-wide association studies (GWASs) have
begun to uncover the molecular roots of this heritability by identifying multiple single-
nucleotide polymorphisms (SNPs) associated with a higher adult body mass index (BMI;
calculated as weight in kilograms divided by height in meters squared).1 The next step is to
understand how these SNPs influence the development of obesity. Individual differences in
obesity risk emerge during gestation and are further established during infancy and
childhood through accelerated growth trajectories.2,3 Therefore, examination of
developmental phenotypes in relation to genetic risk represents a promising approach to
understand the pathogenesis of obesity.4–6 In this study, we asked how SNPs with replicated
GWAS evidence for association with adult BMI relate to growth across the first 4 decades of
life and to adult obesity in a birth cohort followed up prospectively from birth through 38
years of age.
The SNPs identified in GWASs contribute small increments to obesity risk.7 Aggregating
GWAS-identified SNPs to produce a genome-wide index (a genetic risk score [GRS]) yields
a quantitative measure of inherited predisposition toward a trait, such as BMI.8 This
approach has shown promise in the study of complex diseases, such as diabetes mellitus and
heart disease.9,10 In this study, we used a multilocus genome risk score to test how a genetic
predisposition to higher adult BMI might also relate to developmental phenotypes of growth
during proposed critical periods in the development of obesity. The following 3
developmental phenotypes are of interest: growth during gestation, postnatal growth, and the
adiposity rebound. All correlate with adult BMI and are thought to program risk for adult
obesity.11–13 Therefore, we tested the hypothesis that polygenic risk for adult obesity is
mediated by these developmental phenotypes of rapid early growth (Figure 1).
Understanding when in development genetic risk for obesity manifests can help to refine
research and intervention targets.
If genetic risk is mediated through early growth, knowledge of how measured genetic risk
compares with parental BMI in predicting children’s growth and obesity risk is important.
We thus tested whether obesity risk information contained in the GRS was independent of
obesity risk information contained in the BMIs of the children’s parents. That is, does the
GRS contain novel information about children’s risk for obesity beyond their family
history?
Belsky et al. Page 2















Participants are members of the Dunedin Multidisciplinary Health and Development Study,
a longitudinal investigation of health and behavior in a complete birth cohort. Study
members (1037 members; 91% of eligible births; 52% male) were all individuals born
between April 1972 and March 1973 in Dunedin, New Zealand, who were eligible for the
longitudinal study based on residence in the province and who participated in the first
follow-up assessment at 3 years of age. The cohort represents the full range of
socioeconomic status in the general population of New Zealand’s South Island and is
primarily white. Assessments were performed at birth and at ages 3, 5, 7, 9, 11, 13, 15, 18,
21, 26, 32, and, most recently, 38 years, with greater than 95% retention. At each
assessment, study members are brought to the Dunedin research unit for a full day of
interviews and examinations. The Otago Ethics Committee approved each phase of the
study. The study protocol was approved by the institutional ethical review boards of the
participating universities. Informed consent was obtained from all study members.
MAIN EXPOSURES
Obesity GRS—We derived a 32-SNP GRS from published GWASs of BMI, obesity,
weight, and waist circumference in populations of European descent. The construction of the
GRS is described in the eMethods (http://www.archpediatrics.com). We validated our GRS
as a measure of obesity risk in data from the Atherosclerosis Risk in Communities (ARIC)
sample.16 ARIC cohort members of European descent who had higher GRSs were larger as
measured by BMI, weight, and waist circumference (r>0.10 [P<1×10−20]) and were more
likely to be obese (relative risk, 1.73 [95% CI, 1.51–1.97] for individuals in the highest vs
the lowest quintile of the GRS distribution).
We genotyped the 32 GRS SNPs in the Dunedin Study cohort with a commercially available
array (BeadPlex Array; Illumina, Inc) using DNA extracted from whole blood (93% of the
sample) or buccal swabs (7% of the sample). Of the 32 GRS SNPs, 29 were called
successfully in more than 95% of the cohort, and we constructed the final score from these
SNPs (eTable 1). Comparison of the 29-SNP GRS with the original 32-SNP GRS in the
ARIC sample revealed no differences in score distribution or effect sizes. Dunedin Study
members carried 15 to 36 risk alleles (mean [SD], 26.04 [3.32]). After weighting, GRS
values ranged from 13.71 to 35.04 (mean [SD], 24.71 [3.59]) (eFigure 1). The GRS was
standardized to have a mean of 0 and an SD of 1 for analyses.
Family History of Obesity—Parental BMI was available for 97.82% of the cohort.
Parental BMIs were computed from self-reports of height and weight when children were 11
years of age. To measure familial predisposition to obesity, parental BMIs were
standardized within sex, and the standardized scores were averaged to create a single family
history score.
OUTCOME MEASURES
Body Mass Index—Individuals’ height and weight were measured at ages 3, 5, 7, 9, 11,
13, 15, 18, 21, 26, 32, and 38 years. Height was measured to the nearest millimeter using a
portable stadiometer (Harpenden; Holtain, Ltd). Weight was measured to the nearest 0.1 kg
at ages 3, 5, 7, 9, 11, 13, 15, 18, 21, 26, 32, and 36 years using calibrated scales. Individuals
were weighed in light clothing. Obesity was defined at 15 years of age using US Centers for
Disease Control and Prevention cutoff points (BMI≥24.64 for boys; BMI≥25.46 for girls),
which show predictive validity for obesity and coronary heart disease in young adulthood
that is similar to the International Obesity Task Force cutoff points.17 Obesity was defined at
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ages 18 to 38 years as a BMI of 30 or greater. Individuals who met obesity criteria for at
least 50% of 6 measurements from ages 15 to 38 years were classified as chronically
obese.18
Additional Measures of Adiposity—At ages 7 and 9 years, tricep and subscapular
skinfold thicknesses were measured by trained anthropometrists. At ages 26, 32, and 38
years, waist girth was measured by averaging 2 measurements of the perimeter at the level
of the noticeable waist narrowing. At ages 32 and 38 years, fat mass was measured using a
body composition analyzer (BC 418; Tanita) to assess bio-electrical impedence.19
Developmental Phenotypes of Early Growth—Rate of early-childhood weight gain
was assessed as the difference between weight at birth (from hospital records) and weight at
3 years of age. Adiposity rebound was calculated as the nadir of each individual’s childhood
BMI curve fitted across ages 3 through 13 years. We used multilevel longitudinal modeling
to fit individual growth curves.20 Models included linear and quadratic slope terms and were
adjusted for sex. Children in our sample experienced adiposity rebound at about 6 years of
age (mean [SD] age, 6.11 [1.10] years) at a BMI of approximately 16 (mean [SD], 15.57
[1.00]).
STATISTICAL ANALYSIS
We analyzed life-course growth using a multilevel longitudinal growth model20 fitted to
BMI measurements at ages 3, 5, 7, 9, 11, 13, 15, 18, 21, 26, 32, and 38 years. We set the
intercept at 13 years of age. We modeled separate linear and quadratic slopes for growth
during childhood (ages 3–13 years) and adulthood (ages 13–38 years). The intercept
captured the sample mean BMI at 13 years of age (β=19.97). Slope coefficients captured
annual change/acceleration in BMI. Linear slope terms captured change in BMI across
childhood (β=1.19) and adulthood (β=0.51). Quadratic slope terms captured acceleration of
change, that is, the concavity of the trajectory in childhood (β=0.08) and the convexity of
the trajectory in adulthood (β=−0.01). All model terms were statistically significant (P<.
001).
We tested genetic influence on growth by modeling the intercept and linear slope terms of
the life-course growth curve as functions of the GRS and covariates. The GRS coefficients
measured the effect of a 1-SD increase in genetic risk on BMI at 13 years of age (intercept)
and on the linear change per year in BMI from ages 3 through 13 years (childhood slope)
and ages 13 through 38 years (adulthood slope).
We tested genetic associations with cross-sectional measurements of BMI and with other
quantitative traits using linear regression models. The GRS coefficients were standardized to
effect-size correlations (Pearson r) for ease of interpretation. We tested genetic associations
with obesity risk using Poisson regression models. The GRS coefficients were exponentiated
to compute relative risks. We tested mediation of genetic risk for obesity through
developmental phenotypes of early growth using the structural equation described by
MacKinnon and Dwyer.21 Mediation analyses decomposed GRS-obesity associations into
direct (unmediated) and indirect (mediated through a developmental phenotype)
components. Statistical tests of mediation were conducted using methods described by
Preacher and colleagues.22–24
All models were adjusted for sex and constituted the 98% (n = 856) of Dunedin Study
members of European descent with available BMI, family history, and genotype data. We
used SAS statistical software (version 9.2)25 for growth modeling and mediation analyses
and STATA (version 11.0)26 for other analyses.
Belsky et al. Page 4














CHILDREN WITH HIGHER GRSs WERE LARGER AND GREW FASTER DURING
CHILDHOOD AND DURING ADULTHOOD
Children with higher GRSs had higher BMIs at every age assessed, from ages 3 through 38
years (Table 1). In the life-course growth model, higher GRSs predicted higher mean levels
of BMI (intercept β=0.38 [P<.001]), faster growth in childhood (β= 0.03 [P <.001]), and
faster growth in adulthood (β=0.02 [P=.02]). Figure 2 shows life-course growth curves for
children with high, low, and average GRSs.
To rule out the possibility that variation at the FTO locus (GenBank NC_007316.4)
accounted for our observed GRS-growth associations, we repeated the analysis, adjusting
slope and intercept estimates for the FTO SNP rs9939609. This SNP is the best-replicated
GWAS result for BMI,27 has been shown to influence growth,6,28 and carried the largest
weight of any SNP in our GRS. Associations of GRS and growth were unchanged by
adjustment for rs9939609. Independent of their rs9939609 genotype, children with higher
GRSs were larger across 4 decades of follow-up (intercept β=0.40 [P<.001]) and grew faster
during childhood and during adulthood (childhood linear slope β =0.03 [P=.003]; adult
linear slope β=0.02 [P=.01]).
To rule out the possibility that GRS-growth associations reflected associations with height
or muscle mass and not with adiposity, we tested associations between the GRS and
childhood skinfold thicknesses and adult waist-girth and fat-mass measurements. These
measurements are less susceptible to inflation as a result of body size and are considered to
be more direct measures of body fat.19 The GRS correlations with these alternative measures
of adiposity were statistically significant and were similar to GRS correlations with BMI
(Table 1).
CHILDREN WITH HIGHER GRSs WERE AT GREATER RISK FOR OBESITY ACROSS 2
DECADES OF ADULT FOLLOW-UP
As teenagers (ages 15–18 years), 5.5% of Dunedin Study children had BMIs in the obese
range; in their third decade of life (ages 21–26 years), 11.2% met criteria for obesity; and in
their fourth decade of life (ages 32–38 years), 22.3% met criteria for obesity, consistent with
the nationwide prevalence among New Zealanders of European descent (http://
socialreport.msd.govt.nz/health/obesity.html). We classified 8.4% of the sample as
chronically obese. Figure 3 shows obesity prevalences for children at low (below average)
and high (above average) genetic risk. Children at high genetic risk were 1.61 to 2.41 times
more likely to be obese in their second, third, and fourth decades of life and were 1.90 times
more likely to be chronically obese across more than 3 assessments compared with children
at low genetic risk.
POLYGENIC RISK FOR ADULT OBESITY IS MEDIATED BY DEVELOPMENTAL
PHENOTYPES OF RAPID CHILDHOOD GROWTH
To determine whether genetic risk for obesity was mediated by rapid early growth, we
investigated relationships among the children’s GRSs, their growth during gestation and
childhood, and their obesity outcomes across ages 15 to 38 years.
The first developmental period theorized to entrain adult obesity risk is gestation. However,
the GRS was not associated with fetal growth as indexed by birth weight (r=0.00 [P>.90])
(Table 1). Nevertheless, by 3 years of age, children at higher genetic risk had higher BMIs
relative to their peers (r =0.08 [P =.04]), raising the question whether growth during a
second developmental period, from birth to 3 years of age, mediated the genetic risk for
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obesity. Children at higher genetic risk gained more weight from birth to 3 years of age
(r=0.09 [P=.01]) (Table 1). Consistent with previous research,29,30 children with more rapid
weight gain during these years were more likely to become obese (Table 2). Decomposition
of GRS-obesity associations into direct and indirect effects indicated that weight gain from
birth to 3 years of age mediated statistically significant portions of genetic risk for obesity in
the teenage years and for chronic obesity, but not for obesity, in the third or fourth decade of
life individually (Table 2).
Adiposity rebound, when children begin to gain body fat after losing it during early
childhood, is a third period in development theorized to entrain adult obesity. For children at
higher genetic risk, adiposity rebound occurred earlier in development and at higher BMI (r
= −0.13 for age and r = 0.17 for BMI [P <.001 for both]) (Table 1). Consistent with previous
research,11,31 children with earlier adiposity rebound and higher BMI at adiposity rebound
were more likely to become obese (Table 2). Decomposition of GRS-obesity associations
into direct and indirect effects revealed that adiposity rebound mediated large and
statistically significant portions of genetic risk for obesity in the second, third, and fourth
decades of life and for chronic obesity (Table 2).
THE GRS CONTAINED INFORMATION ABOUT CHILDREN’S GROWTH AND THEIR RISK
FOR OBESITY IN ADULTHOOD THAT WAS NOT AVAILABLE IN THEIR FAMILY HISTORIES
Higher genetic risk predicted faster growth and increased risk for obesity in children with
normal-weight and overweight parents (Figure 4). That is, the GRS contributed independent
and additive information to the prediction of children’s growth and their risk for obesity in
adulthood beyond the family history information (eTable 2).
COMMENT
We conducted a developmental genetic investigation into the etiology of obesity in a
prospective birth cohort study with 4 decades of follow-up. We measured polygenic risk for
obesity using a multilocus GRS derived from GWASs of obesity-related phenotypes. Our
analyses revealed that polygenic risk for obesity was partly mediated by rapid growth in the
early childhood years after birth. This finding supported our hypothesis that developmental
phenotypes were critical in linking a genetic predisposition to adult obesity. Furthermore,
risk for obesity measured by the genetic risk score was independent of risk information
available in parental BMI.
These findings have implications for clinical practice and for developmental and
epidemiologic research. First, the results suggest promise for using genetic information in
obesity risk assessments. Parental BMI has been proposed as a screening measure to target
obesity prevention in children on the basis of effect-size correlations only slightly larger
than those we report for our GRS.32 New developments in genome science, including next-
generation sequencing, may uncover new variants that further improve the performance of
SNP-based risk assessments.33–35 Moreover, the GRS contained information about
children’s future obesity risk that could not be derived from measurements of parents,
suggesting that positive family history may not always be an appropriate prerequisite for
genetic testing. Second, our findings illustrate how polygenic influences on development can
be investigated using the GRS. Prospective cohort studies containing repeated measures are
necessary to elucidate developmental processes leading to complex diseases.36 However, to
date, small single-locus effect sizes have made it challenging to incorporate genetic
information into ongoing cohort studies. To address the challenge of small effects, we used a
multilocus profile. The resulting GRS enables measurement of a larger, genome-wide effect
size and reduces the number of hypothesis tests to 1, making follow-up of GWAS findings
tractable in cohort studies that are needed to study development. Third, the longitudinal
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results illustrate that investigations of obesity as an outcome to developmental processes can
inform public health initiatives and research priorities by identifying specific phases in
development when genetic risk becomes manifest and thus might be amenable to
intervention. Childhood growth in general—and, in particular, growth during the period
between birth and the adiposity rebound—should be a focus for future research to
understand genetic contributions to the development of obesity.
We acknowledge 3 limitations. First, we derived our GRS from GWASs of Europeans and
conducted our study in individuals of European descent; these results may not generalize to
other populations.37 Second, our family histories included only parents. More complete
family histories might have greater overlap with the GRS. Third, we were unable to
characterize growth trajectories during the earliest stages of life; regular follow-up of the
cohort did not begin until 3 years of age. However, results from our analyses of birth weight
and of weight gain from birth though 3 years of age were consistent with previous genetic
investigations of this interval that did include repeated measurements.5,6,38,39 Moreover, we
were able to capture growth from 3 years of age and onward with a high degree of
resolution; our study included 12 measurements taken during the subsequent 35 years. In
addition to repeated measures of height and weight, our study included more direct measures
of adiposity, including childhood measurements of skinfold thicknesses and adult
measurements of waist circumference and fat mass, all of which were associated with our
GRS in parallel to BMI. Thus, the results present compelling evidence that SNPs identified
in GWASs of adult BMI and other obesity-related phenotypes predispose to more rapid
growth in childhood, leading to increased risk for obesity in adulthood, and provide
information not forthcoming from a simple analysis of family history.
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Developmental phenotypes of rapid early growth hypothesized to mediate polygenic risk for
obesity. The genetic epidemiology of obesity indicates that a large number of common
polymorphisms each contribute small, additive increments to risk for obesity.14,15 The
combined influence of these polymorphisms can be summarized in a polygenic risk profile.8
The developmental epidemiology of obesity highlights the following 3 developmental
phenotypes of rapid early growth that predispose children to become obese in later life: (1)
growth during gestation, (2) postnatal growth, and (3) adiposity rebound.11,12 We tested the
hypothesis that these developmental phenotypes would mediate polygenic risk for adult
obesity. BMI indicates body mass index.
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Life-course growth curves for children with high, low, and average genetic risk scores
(GRSs). Individuals with higher-obesity GRSs were larger and grew more rapidly as
children and adults. The solid line represents the population mean trajectory (average
genetic risk). Dashed lines are for subgroups within 1 SD of the GRS (high and low genetic
risk). Trajectories were derived from the life-course growth model (intercept fitted at 13
years of age; linear and quadratic slopes fitted during ages 3–13 years and 13–38 years),
including intercept and linear slope effects for the GRS. Analyses included 856 individuals
of European descent. Body mass index is calculated as weight in kilograms divided by
height in meters squared.
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Obesity prevalence among low and high genetic risk cohort members in their second, third,
and fourth decades of life and chronically across ages 15 to 38 years. Individuals with higher
genetic risk scores (GRSs) were more likely to be obese across 2 decades of adult follow-up.
Error bars and numbers in parentheses reflect 95% CIs. The GRS was dichotomized at the
sample mean to create low and high genetic risk categories. Relative risks (RRs) (95% CIs)
are reported from Poisson regression models adjusted for sex that included the 856
individuals of European descent in the analysis sample.
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Influence of genetic risk and family history on growth and obesity risk. The genetic risk
score (GRS) contained information about children’s growth and their obesity risk that was
not available in their family histories. Genetic risk and family history made independent and
additive contributions to life-course growth predictions and to adult obesity risk in 856
individuals of European descent. A, Life-course growth curves show that genetic risk and
family history made additive contributions to growth predictions. B, Bar graph shows that
genetic risk and family history made additive contributions to children’s risk of becoming
obese. Error bars reflect 95% CIs. Statistical analyses illustrating the independence of the
GRS and family history in predicting growth and obesity risk are presented in eTable 2.
Body mass index is calculated as weight in kilograms divided by height in meters squared.
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Table 1
Descriptive Statistics and Correlations With GRS and Family History Score for Anthropometric Assessments
Among 856 Individuals of European Descent
Assessmenta Mean (SD) Measurement
Correlation, r
With GRSb With Family History Scoreb
BMI
 3 16.33 (1.28) 0.08c 0.11d
 5 15.88 (1.18) 0.13e 0.19e
 7 15.82 (1.29) 0.17e 0.24e
 9 16.33 (1.62) 0.18e 0.21e
 11 17.49 (2.09) 0.16e 0.22e
 13 19.59 (2.47) 0.18e 0.23e
 15 20.37 (2.60) 0.17e 0.30e
 18 22.73 (3.02) 0.15e 0.31e
 21 23.74 (3.41) 0.18e 0.31e
 26 24.89 (4.27) 0.16e 0.29e
 32 26.03 (4.80) 0.13e 0.31e
 38 26.92 (5.13) 0.14e 0.34e
Alternative measures of adiposity
  Subscapular skinfold thickness, mm
   7 5.87 (1.92) 0.07d 0.12d
   9 6.67 (2.80) 0.11e 0.10d
  Tricep skinfold thickness, mm
   7 8.46 (2.46) 0.07c 0.10d
   9 11.06 (4.12) 0.09d 0.10d
  Waist circumference, mm
   26 798.68 (96.40) 0.14e 0.24e
   32 841.81 (110.95) 0.11e 0.25e
   38 858.39 (122.84) 0.12e 0.26e
  Fat mass, kg
   32 21.41 (10.54) 0.10d 0.23e
   38 23.59 (10.96) 0.11d 0.27e
Gestational and childhood growth
  Birth weight, kg 3.38 (0.52) 0.00 0.07c
  Weight gain from birth to age 3 y, kg 11.31 (1.52) 0.09c 0.02
  Adiposity rebound
   Age, y 6.11 (1.10) −0.13e −0.21e
   BMI 15.57 (1.00) 0.17e 0.23e
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Abbreviations: BMI, body mass index (calculated as weight in kilograms divided by height in meters squared); GRS, genetic risk score.
a
Unless otherwise indicated, all measurements are given by year of age at which the measurement was obtained.
b
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